Pulmonary Rehabilitation US Reimbursement Update: 2024

Despite well-established evidence of pulmonary rehabilitation (PR)effectiveness, inadequate US reimbursement has resulted in challenges that negatively impact PR financial stability, equity and access. The road to equitable payment and access to PR is a long and complex journey. All major pulmonary societies are working together to improve equity of PR reimbursement. ATS recently published a PR clinical practice guideline to update the evidence base of PR and further substantiate and define PR’s highly effective impact. As the evidence base of effectiveness improves, we all play a role in understanding and working toward improving patient program access, awareness, and adequate payment.